Validation of the classification criteria for cryoglobulinaemic vasculitis

The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV). Twenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) an...

Full description

Saved in:
Bibliographic Details
Published inRheumatology Vol. 53; no. 12; pp. 2209 - 2213
Main Authors QUARTUCCIO, Luca, ISOLA, Miriam, Corazza L, Ramos Casals M, Retamozo S, Ragab GM, Zoheir MN, El Menyawi MA, Salem MN, Sansonno D, Ferraccioli G, Gremese E, Tzioufas A, Voulgarelis M, Vassilopoulos D, Scarpato S, Pipitone N, Salvarani C, Guillevin L, Terrier B, Cacoub P, Filippini D, Saccardo F, Gabrielli A, Fraticelli P, Sebastiani M, Tomsic M, Tavoni A, Mazzaro C, Pioltelli P, Nishimoto N, Scaini P, Zignego AL, Ferri C, Monti G, Pietrogrande M, Bombardieri S, Galli M, DE VITA, Salvatore
Format Journal Article
LanguageEnglish
Japanese
Published England Oxford University Press (OUP) 01.12.2014
Subjects
Online AccessGet full text
ISSN1462-0324
1462-0332
1462-0332
DOI10.1093/rheumatology/keu271

Cover

Loading…
Abstract The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV). Twenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) and subjects without cryoglobulins but with clinical features that can be observed in the course of CV (group C), were studied. Positivity of serum cryoglobulins was necessary for CV classification. Sensitivity and specificity of the criteria were calculated by comparing group A vs group B. The group A vs group C comparison was done to demonstrate the possible diagnostic utility of the criteria. The study included 268 patients in group A, 182 controls in group B and 193 controls in group C (small vessel vasculitis, 51.8%). The questionnaire (at least 2/3 positive answers) showed 89.0% sensitivity and 93.4% specificity; the clinical item (at least 3/4 clinical involvement) showed 75.7% sensitivity and 89.0% specificity and the laboratory item (at least 2/3 laboratory data) showed 80.2% sensitivity and 62.4% specificity. The sensitivity and specificity of the classification criteria (at least 2/3 positive items) were 89.9% and 93.5%, respectively. The comparison of group A with group C demonstrated the clinical utility of the criteria in differentiating CV from CV mimickers. Classification criteria for CV were validated in a second, large, international study confirming good sensitivity and specificity in a complex systemic disease.
AbstractList The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV). Twenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) and subjects without cryoglobulins but with clinical features that can be observed in the course of CV (group C), were studied. Positivity of serum cryoglobulins was necessary for CV classification. Sensitivity and specificity of the criteria were calculated by comparing group A vs group B. The group A vs group C comparison was done to demonstrate the possible diagnostic utility of the criteria. The study included 268 patients in group A, 182 controls in group B and 193 controls in group C (small vessel vasculitis, 51.8%). The questionnaire (at least 2/3 positive answers) showed 89.0% sensitivity and 93.4% specificity; the clinical item (at least 3/4 clinical involvement) showed 75.7% sensitivity and 89.0% specificity and the laboratory item (at least 2/3 laboratory data) showed 80.2% sensitivity and 62.4% specificity. The sensitivity and specificity of the classification criteria (at least 2/3 positive items) were 89.9% and 93.5%, respectively. The comparison of group A with group C demonstrated the clinical utility of the criteria in differentiating CV from CV mimickers. Classification criteria for CV were validated in a second, large, international study confirming good sensitivity and specificity in a complex systemic disease.
The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV).OBJECTIVEThe aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV).Twenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) and subjects without cryoglobulins but with clinical features that can be observed in the course of CV (group C), were studied. Positivity of serum cryoglobulins was necessary for CV classification. Sensitivity and specificity of the criteria were calculated by comparing group A vs group B. The group A vs group C comparison was done to demonstrate the possible diagnostic utility of the criteria.METHODSTwenty-three centres were involved. New patients with CV (group A) and controls, i.e. subjects with serum cryoglobulins but lacking CV based on the gold standard of clinical judgment (group B) and subjects without cryoglobulins but with clinical features that can be observed in the course of CV (group C), were studied. Positivity of serum cryoglobulins was necessary for CV classification. Sensitivity and specificity of the criteria were calculated by comparing group A vs group B. The group A vs group C comparison was done to demonstrate the possible diagnostic utility of the criteria.The study included 268 patients in group A, 182 controls in group B and 193 controls in group C (small vessel vasculitis, 51.8%). The questionnaire (at least 2/3 positive answers) showed 89.0% sensitivity and 93.4% specificity; the clinical item (at least 3/4 clinical involvement) showed 75.7% sensitivity and 89.0% specificity and the laboratory item (at least 2/3 laboratory data) showed 80.2% sensitivity and 62.4% specificity. The sensitivity and specificity of the classification criteria (at least 2/3 positive items) were 89.9% and 93.5%, respectively. The comparison of group A with group C demonstrated the clinical utility of the criteria in differentiating CV from CV mimickers.RESULTSThe study included 268 patients in group A, 182 controls in group B and 193 controls in group C (small vessel vasculitis, 51.8%). The questionnaire (at least 2/3 positive answers) showed 89.0% sensitivity and 93.4% specificity; the clinical item (at least 3/4 clinical involvement) showed 75.7% sensitivity and 89.0% specificity and the laboratory item (at least 2/3 laboratory data) showed 80.2% sensitivity and 62.4% specificity. The sensitivity and specificity of the classification criteria (at least 2/3 positive items) were 89.9% and 93.5%, respectively. The comparison of group A with group C demonstrated the clinical utility of the criteria in differentiating CV from CV mimickers.Classification criteria for CV were validated in a second, large, international study confirming good sensitivity and specificity in a complex systemic disease.CONCLUSIONClassification criteria for CV were validated in a second, large, international study confirming good sensitivity and specificity in a complex systemic disease.
Author Pioltelli P
Gabrielli A
Nishimoto N
Ramos Casals M
Salvarani C
Ferri C
Scaini P
Pipitone N
Cacoub P
Scarpato S
Voulgarelis M
Pietrogrande M
Salem MN
Gremese E
Terrier B
Mazzaro C
Galli M
El Menyawi MA
Sebastiani M
Filippini D
Sansonno D
Guillevin L
Saccardo F
Monti G
Tzioufas A
Zoheir MN
Tavoni A
Retamozo S
Ragab GM
Fraticelli P
Ferraccioli G
QUARTUCCIO, Luca
Tomsic M
Zignego AL
Bombardieri S
Corazza L
ISOLA, Miriam
Vassilopoulos D
DE VITA, Salvatore
Author_xml – sequence: 1
  orcidid: 0000-0002-0134-6439
  fullname: QUARTUCCIO, Luca
– sequence: 2
  orcidid: 0000-0002-6391-1720
  fullname: ISOLA, Miriam
– sequence: 3
  fullname: Corazza L
– sequence: 4
  fullname: Ramos Casals M
– sequence: 5
  fullname: Retamozo S
– sequence: 6
  fullname: Ragab GM
– sequence: 7
  fullname: Zoheir MN
– sequence: 8
  fullname: El Menyawi MA
– sequence: 9
  fullname: Salem MN
– sequence: 10
  orcidid: 0000-0001-6520-1653
  fullname: Sansonno D
– sequence: 11
  orcidid: 0000-0002-6884-4301
  fullname: Ferraccioli G
– sequence: 12
  orcidid: 0000-0002-2248-1058
  fullname: Gremese E
– sequence: 13
  orcidid: 0000-0001-6666-8642
  fullname: Tzioufas A
– sequence: 14
  fullname: Voulgarelis M
– sequence: 15
  orcidid: 0000-0003-2288-3863
  fullname: Vassilopoulos D
– sequence: 16
  fullname: Scarpato S
– sequence: 17
  fullname: Pipitone N
– sequence: 18
  orcidid: 0000-0001-5426-5133
  fullname: Salvarani C
– sequence: 19
  fullname: Guillevin L
– sequence: 20
  fullname: Terrier B
– sequence: 21
  orcidid: 0000-0002-6727-4992
  fullname: Cacoub P
– sequence: 22
  fullname: Filippini D
– sequence: 23
  fullname: Saccardo F
– sequence: 24
  fullname: Gabrielli A
– sequence: 25
  orcidid: 0000-0001-8220-9593
  fullname: Fraticelli P
– sequence: 26
  orcidid: 0000-0002-1294-6421
  fullname: Sebastiani M
– sequence: 27
  fullname: Tomsic M
– sequence: 28
  fullname: Tavoni A
– sequence: 29
  orcidid: 0000-0002-0305-6574
  fullname: Mazzaro C
– sequence: 30
  fullname: Pioltelli P
– sequence: 31
  fullname: Nishimoto N
– sequence: 32
  fullname: Scaini P
– sequence: 33
  fullname: Zignego AL
– sequence: 34
  fullname: Ferri C
– sequence: 35
  fullname: Monti G
– sequence: 36
  fullname: Pietrogrande M
– sequence: 37
  fullname: Bombardieri S
– sequence: 38
  orcidid: 0000-0001-8887-6215
  fullname: Galli M
– sequence: 39
  fullname: DE VITA, Salvatore
BackLink https://cir.nii.ac.jp/crid/1872553967477184768$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/24994905$$D View this record in MEDLINE/PubMed
BookMark eNqFkEtLxDAYRYOM6Pj4BYJ04cLNaJ5Ns5TBJwNu1G1J0kSDaTMmqTD_3o4dB3HjJskN53zw3QMw6UJnADhB8AJBQS7jm-lbmYMPr6vLd9NjjnbAFNESzyAheLJ9Y7oPjlNyCkJIuYCo2gP7mApBBWRT8PAivWtkdqErgi3ymym0lwNvnR5_dXTZRCcLG-IQVuHVB9V710nTOl18yqSHlF06ArtW-mSON_cheL65fprfzRaPt_fzq8VMUwjzzEBKGtzwyirEDWs0ZQgJpiimCDFuK6KkqaglJbPElI2iSJSqolSVQkHNySE4H-cuY_joTcp165I23svOhD7VqMRcMMgIHNDTDdqr1jT1MrpWxlX9s_8AkBHQMaQUjd0iCNbrouvfRddj0YMl_lja5e-2cpTO_-OejW7n3KCtT1RxzBgRJaeco4rysiJfF9CU5g
CitedBy_id crossref_primary_10_1016_j_medcli_2021_11_017
crossref_primary_10_1016_j_autrev_2016_09_006
crossref_primary_10_1016_j_jare_2016_11_002
crossref_primary_10_1002_hep_32281
crossref_primary_10_1016_j_jare_2016_02_006
crossref_primary_10_1093_rheumatology_kew194
crossref_primary_10_3389_fcvm_2021_744648
crossref_primary_10_1016_j_aohep_2019_04_010
crossref_primary_10_1007_s00393_017_0356_7
crossref_primary_10_1016_j_rbr_2017_07_510
crossref_primary_10_1016_j_semarthrit_2020_07_013
crossref_primary_10_1371_journal_pone_0117420
crossref_primary_10_30841_2307_5112_4_2019_184366
crossref_primary_10_1080_1744666X_2023_2249609
crossref_primary_10_1016_j_medcle_2021_11_009
crossref_primary_10_1038_s41598_024_60490_z
crossref_primary_10_4103_1319_2442_394001
crossref_primary_10_1002_art_41434
crossref_primary_10_1007_s11739_017_1683_z
crossref_primary_10_1016_j_rdc_2014_09_008
crossref_primary_10_1080_1744666X_2019_1649596
crossref_primary_10_3390_jcm14020556
crossref_primary_10_1093_ndt_gfv335
crossref_primary_10_1007_s00393_016_0076_4
crossref_primary_10_3389_fimmu_2024_1385086
crossref_primary_10_1111_apt_14845
crossref_primary_10_1097_RHU_0000000000001041
crossref_primary_10_1007_s11926_015_0526_z
crossref_primary_10_1186_s44158_024_00141_x
crossref_primary_10_3390_jcm13206069
crossref_primary_10_1016_j_ajg_2018_06_003
crossref_primary_10_1016_j_nephro_2016_01_010
crossref_primary_10_1111_cei_12690
crossref_primary_10_23736_S0026_4806_24_09170_5
crossref_primary_10_1038_s41572_018_0009_4
crossref_primary_10_1016_j_autrev_2022_103034
crossref_primary_10_1038_nrdp_2016_47
crossref_primary_10_14309_ajg_0000000000001667
crossref_primary_10_1016_j_ejr_2018_01_001
crossref_primary_10_23736_S0026_4806_20_07158_X
crossref_primary_10_1007_s10067_021_06032_8
crossref_primary_10_1186_s13075_017_1280_6
crossref_primary_10_1016_j_berh_2018_10_003
crossref_primary_10_1080_17512433_2017_1357466
crossref_primary_10_1002_acr_23770
crossref_primary_10_1080_1744666X_2019_1656527
crossref_primary_10_3389_fimmu_2021_580271
crossref_primary_10_1016_j_ebiom_2018_08_007
crossref_primary_10_1080_14728214_2019_1634052
crossref_primary_10_1097_BOR_0000000000000757
crossref_primary_10_1007_s10875_023_01444_4
crossref_primary_10_1136_bcr_2018_229059
crossref_primary_10_1111_nan_12413
crossref_primary_10_1155_2022_9171284
crossref_primary_10_1007_s00296_018_4192_0
crossref_primary_10_3389_fimmu_2024_1450048
crossref_primary_10_1016_j_transci_2018_06_005
crossref_primary_10_1016_j_autrev_2021_102923
crossref_primary_10_1016_j_monrhu_2017_04_004
Cites_doi 10.1136/ard.2011.150755
10.1002/art.1780341221
10.1093/rheumatology/kem209
10.1002/art.27584
10.1136/jcp.55.1.4
10.1016/0002-9343(66)90199-9
10.1136/annrheumdis-2013-204424
10.1002/art.23015
10.1002/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO;2-8
10.1002/art.23018
10.1056/NEJM199211193272104
ContentType Journal Article
Contributor Saccardo, Francesco
De Vita, Salvatore
Zignego, ANNA LINDA
Zoheir, Mostafa N. aguib
Scarpato, Salvatore
Pioltelli, Pietro
Bombardieri, Stefano
Guillevin, Loic
Ramos Casals, Manuel
Sebastiani, Marco
Ferri, Clodoveo
Filippini, Davide
Cacoub, Patrice
Tomsic, Matija
Pipitone, Nicolò
Galli, Massimo
Mazzaro, Cesare
Sansonno, Domenico Ettore
Scaini, Patrizia
Corazza, Laura
Ragab, Gaafar M. ohamed
Salem, Mohamed N. abil
Quartuccio, Luca
Voulgarelis, Michael
Monti, Giuseppe
Vassilopoulos, Dimitri
Pietrogrande, Maurizio
Retamozo, Soledad
Ferraccioli, Gianfranco
Nishimoto, Norihiro
Gremese, Elisa
Gabrielli, Armando
Tzioufas, Athanasio
Tavoni, Antonio
Isola, Miriam
Salvarani, Carlo
Fraticelli, Paolo
El Menyawi, Manal A. bdel Moneim
Terrier, Benjamin
Contributor_xml – sequence: 1
  fullname: Quartuccio, Luca
– sequence: 2
  fullname: Isola, Miriam
– sequence: 3
  fullname: Corazza, Laura
– sequence: 4
  fullname: Ramos Casals, Manuel
– sequence: 5
  fullname: Retamozo, Soledad
– sequence: 6
  fullname: Ragab, Gaafar M. ohamed
– sequence: 7
  fullname: Zoheir, Mostafa N. aguib
– sequence: 8
  fullname: El Menyawi, Manal A. bdel Moneim
– sequence: 9
  fullname: Salem, Mohamed N. abil
– sequence: 10
  fullname: Sansonno, Domenico Ettore
– sequence: 11
  fullname: Ferraccioli, Gianfranco
– sequence: 12
  fullname: Gremese, Elisa
– sequence: 13
  fullname: Tzioufas, Athanasio
– sequence: 14
  fullname: Voulgarelis, Michael
– sequence: 15
  fullname: Vassilopoulos, Dimitri
– sequence: 16
  fullname: Scarpato, Salvatore
– sequence: 17
  fullname: Pipitone, Nicolò
– sequence: 18
  fullname: Salvarani, Carlo
– sequence: 19
  fullname: Guillevin, Loic
– sequence: 20
  fullname: Terrier, Benjamin
– sequence: 21
  fullname: Cacoub, Patrice
– sequence: 22
  fullname: Filippini, Davide
– sequence: 23
  fullname: Saccardo, Francesco
– sequence: 24
  fullname: Gabrielli, Armando
– sequence: 25
  fullname: Fraticelli, Paolo
– sequence: 26
  fullname: Sebastiani, Marco
– sequence: 27
  fullname: Tomsic, Matija
– sequence: 28
  fullname: Tavoni, Antonio
– sequence: 29
  fullname: Mazzaro, Cesare
– sequence: 30
  fullname: Pioltelli, Pietro
– sequence: 31
  fullname: Nishimoto, Norihiro
– sequence: 32
  fullname: Scaini, Patrizia
– sequence: 33
  fullname: Zignego, ANNA LINDA
– sequence: 34
  fullname: Ferri, Clodoveo
– sequence: 35
  fullname: Monti, Giuseppe
– sequence: 36
  fullname: Pietrogrande, Maurizio
– sequence: 37
  fullname: Bombardieri, Stefano
– sequence: 38
  fullname: Galli, Massimo
– sequence: 39
  fullname: De Vita, Salvatore
Copyright The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Copyright_xml – notice: The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/rheumatology/keu271
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1462-0332
EndPage 2213
ExternalDocumentID 24994905
10_1093_rheumatology_keu271
Genre Validation Studies
Multicenter Study
Journal Article
GroupedDBID ---
-E4
.2P
.I3
.XZ
.ZR
08P
0R~
18M
1TH
29P
2WC
354
4.4
48X
53G
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABVGC
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AGINJ
AGKEF
AGORE
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
MHKGH
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O9-
OAUYM
OAWHX
OBH
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
RUSNO
RW1
RXO
RYH
SV3
TCURE
TEORI
TJX
TR2
VVN
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
ZY1
~91
AAYXX
CITATION
.GJ
3O-
AAGKA
AAPGJ
AAWDT
ABNGD
ACFRR
ACUKT
ADMTO
AEHUL
AFFNX
AGQPQ
AHGBF
AQDSO
ATTQO
AZFZN
CAG
CGR
COF
CUY
CVF
ECM
EIF
EIHJH
FEDTE
HVGLF
NPM
NTWIH
O0~
O~Y
PB-
RIG
RNI
RZF
RZO
TMA
ZGI
7X8
ID FETCH-LOGICAL-c400t-e043d2d78fb17e5dc451195b4241157f83bae84f365f3e6db4196b844b69b0c73
ISSN 1462-0324
1462-0332
IngestDate Fri Jul 11 02:20:59 EDT 2025
Mon Jul 21 05:30:22 EDT 2025
Tue Jul 01 01:36:31 EDT 2025
Thu Apr 24 22:52:05 EDT 2025
Thu Jun 26 23:26:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords classification
vasculitis
cryoglobulinaemia
hepatitis C
Language English
Japanese
License The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c400t-e043d2d78fb17e5dc451195b4241157f83bae84f365f3e6db4196b844b69b0c73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-1294-6421
0000-0001-6666-8642
0000-0002-6884-4301
0000-0001-6520-1653
0000-0002-2248-1058
0000-0001-8220-9593
0000-0001-5426-5133
0000-0002-0305-6574
0000-0002-6391-1720
0000-0002-0134-6439
0000-0002-6727-4992
0000-0003-2288-3863
0000-0001-8887-6215
OpenAccessLink https://cir.nii.ac.jp/crid/1872553967477184768
PMID 24994905
PQID 1627950530
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1627950530
pubmed_primary_24994905
crossref_primary_10_1093_rheumatology_keu271
crossref_citationtrail_10_1093_rheumatology_keu271
nii_cinii_1872553967477184768
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-12-01
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-12-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Rheumatology
PublicationTitleAlternate Rheumatology (Oxford)
PublicationYear 2014
Publisher Oxford University Press (OUP)
Publisher_xml – name: Oxford University Press (OUP)
References Brouet ( key 20170522164521_keu271-B8) 1974; 57
Ferri ( key 20170522164521_keu271-B12) 2002; 55
Johnson ( key 20170522164521_keu271-B10) 2007; 57
Gorevic ( key 20170522164521_keu271-B2) 1991; 28
Meltzer ( key 20170522164521_keu271-B1) 1966; 40
De Vita ( key 20170522164521_keu271-B7) 2011; 70
Quartuccio ( key 20170522164521_keu271-B14) 2012; 30
Agnello ( key 20170522164521_keu271-B5) 1992; 327
Quartuccio ( key 20170522164521_keu271-B6) 2007; 46
De Vita ( key 20170522164521_keu271-B13) 2011; 29
van den Hoogen ( key 20170522164521_keu271-B16) 2013; 72
Aletaha ( key 20170522164521_keu271-B15) 2010; 62
Ferri ( key 20170522164521_keu271-B4) 1991; 34
Invernizzi ( key 20170522164521_keu271-B11) 1995; 13
Dougados ( key 20170522164521_keu271-B9) 2007; 57
De Vita ( key 20170522164521_keu271-B3) 2000; 43
References_xml – volume: 70
  start-page: 1183
  year: 2011
  ident: key 20170522164521_keu271-B7
  article-title: Preliminary classification criteria for the cryoglobulinaemic vasculitis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2011.150755
– volume: 34
  start-page: 1606
  year: 1991
  ident: key 20170522164521_keu271-B4
  article-title: Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780341221
– volume: 13
  start-page: S123
  year: 1995
  ident: key 20170522164521_keu271-B11
  article-title: Classification of the cryoglobulinemic syndrome
  publication-title: Clin Exp Rheumatol
– volume: 46
  start-page: 1657
  year: 2007
  ident: key 20170522164521_keu271-B6
  article-title: Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kem209
– volume: 28
  start-page: 79
  year: 1991
  ident: key 20170522164521_keu271-B2
  article-title: Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases
  publication-title: Semin Hematol
– volume: 62
  start-page: 2569
  year: 2010
  ident: key 20170522164521_keu271-B15
  article-title: 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27584
– volume: 55
  start-page: 4
  year: 2002
  ident: key 20170522164521_keu271-B12
  article-title: Cryoglobulins
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.55.1.4
– volume: 40
  start-page: 828
  year: 1966
  ident: key 20170522164521_keu271-B1
  article-title: Cryoglobulinemia—a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability
  publication-title: Am J Med
  doi: 10.1016/0002-9343(66)90199-9
– volume: 30
  start-page: S48
  year: 2012
  ident: key 20170522164521_keu271-B14
  article-title: Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis
  publication-title: Clin Exp Rheumatol
– volume: 72
  start-page: 1747
  year: 2013
  ident: key 20170522164521_keu271-B16
  article-title: 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204424
– volume: 29
  start-page: S99
  year: 2011
  ident: key 20170522164521_keu271-B13
  article-title: Treatment of mixed cryoglobulinemia: a rheumatology perspective
  publication-title: Clin Exp Rheumatol
– volume: 57
  start-page: 1112
  year: 2007
  ident: key 20170522164521_keu271-B9
  article-title: Classification criteria for rheumatic disease: why and how?
  publication-title: Arthritis Rheum
  doi: 10.1002/art.23015
– volume: 57
  start-page: 775
  year: 1974
  ident: key 20170522164521_keu271-B8
  article-title: Biologic and clinical significance of cryoglobulins
  publication-title: A report of 86 cases. Am J Med
– volume: 43
  start-page: 94
  year: 2000
  ident: key 20170522164521_keu271-B3
  article-title: Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO;2-8
– volume: 57
  start-page: 1119
  year: 2007
  ident: key 20170522164521_keu271-B10
  article-title: Classification criteria in rheumatic diseases: a review of methodologic properties
  publication-title: Arthritis Rheum
  doi: 10.1002/art.23018
– volume: 327
  start-page: 1490
  year: 1992
  ident: key 20170522164521_keu271-B5
  article-title: A role for hepatitis C virus infection in type II cryoglobulinemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199211193272104
SSID ssib000479018
ssib000588979
ssib000829807
ssib058575242
ssib017358208
ssib024195679
ssib032048062
ssib008873835
ssib007540058
ssj0005138
Score 2.4062934
Snippet The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV). Twenty-three centres were involved. New patients with...
The aim of this study was to validate the classification criteria for cryoglobulinaemic vasculitis (CV).OBJECTIVEThe aim of this study was to validate the...
SourceID proquest
pubmed
crossref
nii
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2209
SubjectTerms Adult
Aged
Case-Control Studie
Case-Control Studies
classification
classification; cryoglobulinaemia; hepatitis C; vasculitis; Adult; Aged; Case-Control Studies; Cryoglobulinemia; Female; Hepatitis C; Humans; Male; Middle Aged; Questionnaires; Sensitivity and Specificity; Systemic Vasculitis; Medicine (all)
classification; cryoglobulinaemia; hepatitis C; vasculitis; Adult; Aged; Case-Control Studies; Cryoglobulinemia; Female; Hepatitis C; Humans; Male; Middle Aged; Sensitivity and Specificity; Surveys and Questionnaires; Systemic Vasculitis; Medicine (all)
cryoglobulinaemia
Cryoglobulinemia
Cryoglobulinemia - classification
Cryoglobulinemia - complications
Cryoglobulinemia - diagnosis
Female
Hepatitis C
Hepatitis C - complications
hepatitis C virus; Mixed Cryoglobulinemia; cryoglobulinemic vasculitis; classification
Human
Humans
Male
Medicine (all)
Middle Aged
Questionnaires
Sensitivity and Specificity
Surveys and Questionnaire
Surveys and Questionnaires
Systemic Vasculiti
Systemic Vasculitis
Systemic Vasculitis - classification
Systemic Vasculitis - diagnosis
Systemic Vasculitis - etiology
vasculiti
vasculitis
Title Validation of the classification criteria for cryoglobulinaemic vasculitis
URI https://cir.nii.ac.jp/crid/1872553967477184768
https://www.ncbi.nlm.nih.gov/pubmed/24994905
https://www.proquest.com/docview/1627950530
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXYkBAvE990MBQkHglLbOfrEU0bY-qGNLWob1H8Ea2CJahtJOiv59hO0lQbaPAStVdxnPheXZ1rHx8T8o6qNBZKpL5E-eFzLpWfZmEGIKeE1kkcFVZ4_vwiPp3ys1k0WGi3u0tW4oNc37qv5H-8Chv8anbJ_oNn-4fCgN_wL67wMK538vFXgGjVYz4DIaUBw4b946xICUaLubBkQrn4VRv9D8M9Lywn3tFQjarREKNeXukGONaJMxk10p8dAb498WMwe2A5oY2UczvjOm42xJ_P-PTCEfPxAtf9WgdCbr0uui3Z_e2XxXW99I-KJQbN7SGqmpbN385JhHzA73BplMcwsHbmUt9ia3OvEwruYowOMym1sgk3U7yTv1oMhgJ_v-mGuqNctiW1L77kJ9PxOJ8czyY75D5FLWGOufg0G_CAQnvcef96nTRVxg6HnRy6Lrbgy041n_-5MrEIZfKI7LWlhffRxcljck9XT8iD85Y88ZScbcLFq0sP4eJth4vXhYsHh3s3wsXbhMszMj05nhyd-u1RGr5Ekl75OuBMUZWkpQgTHSlpZOmySHAAuDBKypSJQqe8ZHFUMh0rwZGZRcq5iDMRyIQ9J7tVXemXxJPAqAplNU1EyWWBhirQgYBJBaVm4YjQboRy2erMm-NOvueO78Dy4bDmblhH5H3f6IeTWfn77QcYejzeXMM0QV3MshiVMZAWRwE9Im87p-RIl2YNrKh03SzzMKZJBtTPghF54bzVd0hR_fMsiPbv0PoVebgJ_Ndkd7Vo9AHg6Uq8seH1Gz8Flkg
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+the+classification+criteria+for+cryoglobulinaemic+vasculitis&rft.jtitle=Rheumatology+%28Oxford%2C+England%29&rft.au=Quartuccio%2C+Luca&rft.au=Isola%2C+Miriam&rft.au=Corazza%2C+Laura&rft.au=Ramos-Casals%2C+Manuel&rft.date=2014-12-01&rft.issn=1462-0332&rft.eissn=1462-0332&rft.volume=53&rft.issue=12&rft.spage=2209&rft_id=info:doi/10.1093%2Frheumatology%2Fkeu271&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-0324&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-0324&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-0324&client=summon